• Top 10 COVID-19 Infographics of 2020

  Ryan Syrek, MA | December 21, 2020 | Contributor InformationEvery week, we identify the top search term or phrase, based on increased interest from medical professionals. We then compile the find

  2020-12-21

• Toll-like receptor signalling in B cells during systemic lupus erythematosus

  AbstractB lymphocytes have a central role in autoimmune diseases, which are often defined by specific autoantibody patterns and feature a loss of B cell tolerance. A prototypic disease associated with

  2020-12-18

• Youth Depression Tied to a Wide Range of Illnesses, Early Death

  Children and adolescents with depression may be at dramatically increased risk for premature death or an array of diseases later in life, new research suggests.Youths with depression had a significant

  2020-12-17

• High Blood Pressure at Any Age Speeds Cognitive Decline

  Individuals who have hypertension at any age are more likely to experience more rapid cognitive decline compared to their counterparts with normal blood pressure, new research shows.In a retrospective

  2020-12-16

• FDA Approves Shorter Infusion Time for MS Drug Ocrelizumab

  The US Food and Drug Administration (FDA) has approved a shorter infusion time for ocrelizumab (Ocrevus) for patients with relapsing or primary progressive multiple sclerosis (MS),

  2020-12-15

• Smartphone-powered iontophoresis-microneedle array patch for controlled transdermal delivery

  AbstractThe incidence rate of diabetes has been increasing every year in nearly all nations and regions. The traditional control of diabetes using transdermal insulin delivery by metal needles is gene

  2020-12-14

• New solution for fast axial scanning in fluorescence microscopy

  AbstractA novel technique based on the remote-focusing concept, using a galvanometer scanner combined with a self-fabricated “step mirror” or “tilted mirror” to transform fast lateral scanning into ax

  2020-12-14

• Adding Atezolizumab to Chemo Doesn't Worsen QOL in Early TNBC

  Adding the immune checkpoint inhibitor atezolizumab to first-line therapy for early triple-negative breast cancer (TNBC) did not significantly worsen patients' quality of life, according to new da

  2020-12-14